Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infectionsMark Sulkowski, Richard D. Moore, David L. Thomas et al.|Hepatology|2002Cited by 521
Protection against persistence of hepatitis CShruti H. Mehta, David L. Thomas, Andrea L. Cox et al.|The Lancet|2002Cited by 439
Hepatitis C Virus Infection and Incident Type 2 DiabetesShruti H. Mehta, David L. Thomas, Steffanie A. Strathdee et al.|Hepatology|2003Cited by 405
Limited Uptake of Hepatitis C Treatment Among Injection Drug UsersShruti H. Mehta, David L. Thomas, Becky L. Genberg et al.|Journal of Community Health|2007Cited by 327
Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis CAshwin Balagopal, Stuart C. Ray, Frances Hite Philp et al.|Gastroenterology|2008Cited by 280